Skip to main content
. 2022 Dec 10;39:100558. doi: 10.1016/j.ctro.2022.12.001

Fig. 4.

Fig. 4

Kaplan-Meier curves of overall survival from the initiation of pembrolizumab for patients treated with or without the concurrent palliative radiation with pembrolizumab in pair-matched groups. Log-rank test was examined to determine the survival difference.